Navigation Links
NewLink Genetics Announces Timing of Fourth Quarter and Year-End 2012 Financial Results Conference Call
Date:2/25/2013

AMES, Iowa, Feb. 25, 2013 /PRNewswire/ -- NewLink Genetics Corporation (Nasdaq: NLNK) today announced that its Fourth Quarter and fiscal year ended December 31, 2012 financial results will be released before the market opens on Thursday, February 28, 2013.  The NewLink management team will host a conference call discussing the company's financial results and recent corporate developments on Thursday, February 28, 2013, at 10:00am EST.  The call can be accessed by dialing 1-(877) 363-5052 (domestic) or 1-(914) 495-8600 (international) five minutes prior to the start of the call and providing the passcode 16064630.  A replay of the call will be available approximately two hours after the completion of the call and can be accessed by dialing 1-(855) 859-2056 (domestic) or 1-(404) 537-3406 (international), providing the passcode 16064630.  The replay will be available for two weeks from the date of the live call.

The live, listen-only webcast of the conference call can be accessed by visiting the investors section of the NewLink website at http://investors.linkp.com/.  A replay of the webcast will be archived on the company's website for two weeks following the call.

About NewLink Genetics Corporation

NewLink Genetics Corporation is a biopharmaceutical company focused on discovering, developing and commercializing novel immunotherapeutic products to improve cancer treatment options for patients and physicians.  NewLink's portfolio includes biologic and small-molecule immunotherapy product candidates intended to treat a wide range of oncology indications.

Contacts:  
Gordon Link  
Chief Financial Officer   
NewLink Genetics  
1.515.598.2925  
glink@linkp.com   


'/>"/>
SOURCE NewLink Genetics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. NewLink Genetics Corporation Announces Exercise of Underwriters Option and Closing of Public Offering of Common Stock
2. NewLink Genetics Corporation Announces Pricing of Public Offering of Common Stock
3. NewLink Genetics Corporation Announces Proposed Public Offering of Common Stock
4. Clinical Data from NewLink Genetics HyperAcute Prostate Cancer Immunotherapy Published in Journal of Immunotherapy
5. Lota S. Zoth joins NewLinks Board of Directors; heads Audit Committee
6. Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications, RNA Interference, Cancer Therapeutics, Personalized Medicine) (2012 - 2017)
7. Amgen to Acquire deCODE Genetics, a Global Leader in Human Genetics
8. Submit Questions to Nobel Laureates and Other Experts about Genetics and Society
9. The International Serious Adverse Event Consortium and UC San Diego To Collaborate On Research Into The Genetics Of Drug Induced Renal Injury
10. Millennium Laboratories Announces Landmark Pharmacogenetics Clinical Outcomes Study
11. Epigenetics R&D Pipeline - Histone Deacetylases (HDACs) Offer the Most Promising Targets and Outnumber Other Classes of Epigenetic Targets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/14/2019)... ... September 13, 2019 , ... ... (WMIS) annual congress in Montreal provided a plethora of breakthrough research studies ... Artificial Intelligence (AI) to detect breast cancer, response prediction of cancer immunotherapies ...
(Date:9/14/2019)... TAMPA, Fla. (PRWEB) , ... September 13, 2019 ... ... Carastro Engineering and honored guests joined together to celebrate the structural topping out ... Sept. 10. , The expansion project will include a new six-story patient tower ...
(Date:9/12/2019)... ... September 12, 2019 , ... ... cycle management services, integrated practice management, and patient engagement solutions, announced today ... National User Conference (NUCON) 2019 . The annual conference features informative ...
Breaking Medicine Technology:
(Date:9/17/2019)... ... September 17, 2019 , ... Drs. Charles Felts and ... teeth in Chattanooga, TN for customized full mouth dental implants with TeethXpress® ... one day, providing a permanent tooth replacement solution for patients who struggle with ...
(Date:9/17/2019)... ... September 17, 2019 , ... Specialty Technical ... updated International Audit Protocol Consortium (IAPC) EHS audit protocol for Japan . ... scope of their EHS regulatory obligations and rapidly collect, share, archive, and export ...
(Date:9/14/2019)... , ... September 13, 2019 ... ... (WMIS) showcased several first-in-human studies on the detection and treatment of infectious ... examples of these ground-breaking studies were noninvasive detection of residual HIV infected ...
(Date:9/11/2019)... ... September 11, 2019 , ... A September 2 article ... weight loss surgery were significantly less likely to suffer heart attacks, strokes, kidney failure, ... bariatric surgery. Los Angeles-based weight loss surgery specialists Dr. Feiz and Associates says the ...
(Date:9/11/2019)... ... 11, 2019 , ... Autopsies don’t lie. They report the causes of ... Methamphetamine permanently harms the heart. It increases risks of heart attack and death. ... how the damage occurs. , An August 1, 2019 article in ...
Breaking Medicine News(10 mins):